Mark L. Berch

Array ( [id] => 6083946 [patent_doc_number] => 20110144095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/032685 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54073 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144095.pdf [firstpage_image] =>[orig_patent_app_number] => 13032685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144554 [patent_doc_number] => 20110130362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'A2B ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/016425 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31561 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130362.pdf [firstpage_image] =>[orig_patent_app_number] => 13016425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028325 [patent_doc_number] => 08143249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Prodrugs of A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/011446 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13174 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143249.pdf [firstpage_image] =>[orig_patent_app_number] => 13011446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6084883 [patent_doc_number] => 20110144327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF AZETIDINONES' [patent_app_type] => utility [patent_app_number] => 13/008458 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11440 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144327.pdf [firstpage_image] =>[orig_patent_app_number] => 13008458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039442 [patent_doc_number] => 20110092491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity' [patent_app_type] => utility [patent_app_number] => 12/976187 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19842 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092491.pdf [firstpage_image] =>[orig_patent_app_number] => 12976187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033278 [patent_doc_number] => 20110082139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'SUBSTITUTED 8-[6-AMINO-3-PYRIDYL]XANTHINES' [patent_app_type] => utility [patent_app_number] => 12/967876 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13360 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082139.pdf [firstpage_image] =>[orig_patent_app_number] => 12967876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163101 [patent_doc_number] => 20110160178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'HETEROSUBSTITUTED N-THIOLATED BETA-LACTAM COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/951778 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3832 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160178.pdf [firstpage_image] =>[orig_patent_app_number] => 12951778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199352 [patent_doc_number] => 20120122833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'DEUTERIUM-ENRICHED MEROPENEM' [patent_app_type] => utility [patent_app_number] => 12/944447 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122833.pdf [firstpage_image] =>[orig_patent_app_number] => 12944447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587417 [patent_doc_number] => 20110281927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'DEUTERIUM-ENRICHED DORIPENEM' [patent_app_type] => utility [patent_app_number] => 12/944497 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3149 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281927.pdf [firstpage_image] =>[orig_patent_app_number] => 12944497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071252 [patent_doc_number] => 20110046103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Compositions' [patent_app_type] => utility [patent_app_number] => 12/938660 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9824 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046103.pdf [firstpage_image] =>[orig_patent_app_number] => 12938660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196957 [patent_doc_number] => 20110028715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/905012 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39256 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028715.pdf [firstpage_image] =>[orig_patent_app_number] => 12905012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6121245 [patent_doc_number] => 20110077255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'SUBSTITUTED XANTHINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/874783 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 43815 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077255.pdf [firstpage_image] =>[orig_patent_app_number] => 12874783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026314 [patent_doc_number] => 20110053961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'SUBSTITUTED XANTHINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/873991 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 43802 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053961.pdf [firstpage_image] =>[orig_patent_app_number] => 12873991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007904 [patent_doc_number] => 20110059935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/868277 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32017 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059935.pdf [firstpage_image] =>[orig_patent_app_number] => 12868277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082113 [patent_doc_number] => 08148371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Adenine compound and use thereof' [patent_app_type] => utility [patent_app_number] => 12/793649 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 42605 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148371.pdf [firstpage_image] =>[orig_patent_app_number] => 12793649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268468 [patent_doc_number] => 20100298564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PREPARATION OF AMORPHOUS VALGANCICLOVIR HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/785558 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2754 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298564.pdf [firstpage_image] =>[orig_patent_app_number] => 12785558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152135 [patent_doc_number] => 08168622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'β-lactamase-resistant cephalosporin ester compounds and salts of thereof' [patent_app_type] => utility [patent_app_number] => 12/785388 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7203 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168622.pdf [firstpage_image] =>[orig_patent_app_number] => 12785388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568226 [patent_doc_number] => 20110288289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Preparation of Carbapenem Intermediate and Their Use' [patent_app_type] => utility [patent_app_number] => 12/783166 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5284 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288289.pdf [firstpage_image] =>[orig_patent_app_number] => 12783166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802387 [patent_doc_number] => 08440661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines' [patent_app_type] => utility [patent_app_number] => 12/779083 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35719 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12779083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546293 [patent_doc_number] => 20100222300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'A2B Adenosine Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/776642 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31571 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222300.pdf [firstpage_image] =>[orig_patent_app_number] => 12776642 [rel_patent_id] =>[rel_patent_doc_number] =>)